2016
DOI: 10.1021/acsbiomaterials.5b00476
|View full text |Cite
|
Sign up to set email alerts
|

In Vivo Microcomputed Tomography of Nanocrystal-Doped Tissue Engineered Scaffolds

Abstract: Tissue engineered scaffolds (TES) hold promise for improving the outcome of cell-based therapeutic strategies for a variety of biomedical scenarios, including musculoskeletal injuries, soft tissue repair, and spinal cord injury. Key to TES research and development, and clinical use, is the ability to longitudinally monitor TES location, orientation, integrity, and microstructure following implantation. Here, we describe a strategy for using microcomputed tomography (microCT) to visualize TES following implanta… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
21
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
6
1

Relationship

2
5

Authors

Journals

citations
Cited by 17 publications
(23 citation statements)
references
References 38 publications
0
21
0
Order By: Relevance
“…A more versatile technique for adding contrast to almost any system is the incorporation of nanoparticles . Iron oxide nanoparticles are already in clinical use for therapeutic purposes, such as anemia treatment, and experimental uses such as tracking drug delivery and efficacy in cancer. A wide range of nanoparticles with unique chemistries have been incorporated into matrices, allowing for monitoring via different imaging modalities. Use of these novel materials has shown promise to track in vivo implanted device degradation and location in preclinical settings. , A downside to these studies is that imaging is performed using high-resolution preclinical systems, which are clinically incompatible, or the studies do not use protocols or techniques that are consistent with clinical practices.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…A more versatile technique for adding contrast to almost any system is the incorporation of nanoparticles . Iron oxide nanoparticles are already in clinical use for therapeutic purposes, such as anemia treatment, and experimental uses such as tracking drug delivery and efficacy in cancer. A wide range of nanoparticles with unique chemistries have been incorporated into matrices, allowing for monitoring via different imaging modalities. Use of these novel materials has shown promise to track in vivo implanted device degradation and location in preclinical settings. , A downside to these studies is that imaging is performed using high-resolution preclinical systems, which are clinically incompatible, or the studies do not use protocols or techniques that are consistent with clinical practices.…”
Section: Introductionmentioning
confidence: 99%
“…14−16 Use of these novel materials has shown promise to track in vivo implanted device degradation and location in preclinical settings. 17,18 A downside to these studies is that imaging is performed using high-resolution preclinical systems, which are clinically incompatible, or the studies do not use protocols or techniques that are consistent with clinical practices.…”
Section: Introductionmentioning
confidence: 99%
“…imaging (MRI), [24][25][26][27] and X-ray computed tomography (CT). [28][29][30] Among these, CT imaging is advantageous in providing low-cost, 3D, deep tissue imaging at high spatial and temporal resolution, but is limited by low soft tissue contrast. CT imaging contrast is derived from the X-ray attenuation of the scaffold material relative to adjacent tissue.…”
Section: Introductionmentioning
confidence: 99%
“…[ 13 ] Therefore, various imaging modalities have been investigated for noninvasive assessment of hydrogel degradation and drug delivery, [ 13,14 ] including ultrasound elasticity imaging, [ 15,16 ] photoacoustic imaging, [ 17,18 ] near‐infrared fluorescence imaging, [ 19–24 ] magnetic resonance imaging (MRI), [ 24–27 ] and X‐ray computed tomography (CT). [ 28–30 ] Among these, CT imaging is advantageous in providing low‐cost, 3D, deep tissue imaging at high spatial and temporal resolution, but is limited by low soft tissue contrast.…”
Section: Introductionmentioning
confidence: 99%
“…13 Therefore, various imaging modalities have been investigated for noninvasive assessment of hydrogel degradation and drug delivery, 13,14 including ultrasound elasticity imaging, 15,16 photoacoustic imaging, 17,18 near-infrared fluorescence imaging, [19][20][21][22][23][24] magnetic resonance imaging, [24][25][26][27] and X-ray computed tomography (CT). [28][29][30] Among these, CT imaging is advantageous in providing low cost, three-dimensional (3D), deep tissue imaging at high spatial and temporal resolution, but is limited by low soft tissue contrast.…”
Section: Introductionmentioning
confidence: 99%